How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

Blood

Volumn 96, Issue 4, 2000, Pages 1223-1229

  George, James N ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; HEMOLYTIC UREMIC SYNDROME; MEDICAL DECISION MAKING; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REVIEW; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0034663327     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.4.1223     Document Type: Review

References (47)

1. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
2. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries
3. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature
4. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic
5. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
6. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura
7. Long term clinical outcomes of thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome (TTP-HUS) among different patient groups
8. Hamolytisch-uramische syndrome: Bilaterale nierenrindennekrosen bei akutenerworbenen hamolytischen anamien
9. Hemolytic-uremic syndrome, thrombotic thrombocytopenia purpura, and systemic sclerosis (systemic scleroderma)
10. Escherichia coli O157:H7
11. Atypical hemolytic-uremic syndrome: A comparison with postdiarrheal disease
12. Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak
13. Thrombotic thrombocytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange
14. Thrombotic thrombocytopenic purpura: A simpler diagnosis at last?
15. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura
16. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells
17. Unusually large plasma factor VII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura
18. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
19. Antibodies to von-Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
20. Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura
21. Deficient activity of von Willebrand's factor cleaving protease in patients with disseminated malignancies
22. Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families
23. Therapeutic plasma exchange: An update from the Canadian Apheresis Group
24. Thrombotic thrombocytopenic purpura-like syndrome in the absence of schistocytes
25. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenia purpura
26. Cryopoor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)
27. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
28. Cryo-supematant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura
29. Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura
30. Thrombotic thrombocytopenic purpura: Early and late responders
31. Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange
32. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention
33. Plasma exchange complications in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
34. Central venous catheter placement in patients with disorders of hemostasis
35. Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura
36. Chronic thrombotic thrombocytopenic purpura masquerading as other disease entities
37. Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome
38. Childhood haemolytic uraemic syndrome: Long-term outcome and prognostic features
39. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: Clinical and serological findings in nine patients and review of literature
40. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura hemolytic uremic syndrome in the cancer patient
41. Cyclosporine-associated thrombotic microangiopathy in renal allografts
42. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T cell lymphoma (Sezary syndrome): A case report
43. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
44. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus
45. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients
46. Microangiopathic hemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin
47. Microangiopathic hemolytic anemia: The possible role of vascular lesions in pathogenesis